Company Filing History:
2 out of 4,455 
1 out of 832,843 Years Active: 2007-2009
Title: **Innovator Spotlight: Susan LaGreca**
Introduction
Susan LaGreca is a distinguished inventor based in Old Lyme, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. With a total of three patents to her name, her work is pivotal in advancing cancer treatment methodologies.
Latest Patents
Susan's latest patents focus on the synthesis of substituted pyrrolo[2,3-d]pyrimidine derivatives and substituted pyrrolopyrimidines. The first invention relates to compounds that possess the formula 1 or a pharmaceutically acceptable salt, prodrug, solvate, or hydrate thereof. These compounds are designed to combat abnormal cell growth, specifically cancer, in mammals. The second patent concerns similar compounds useful in treating hyperproliferative disorders and emphasizes the importance of pharmaceutical compositions containing these innovative compounds and their applications in medical treatments.
Career Highlights
Throughout her career, Susan has been associated with Pfizer Corporation, where she has contributed her expertise in drug discovery and development. Her work at a leading pharmaceutical company has been instrumental in bridging the gap between innovative research and practical application in the medical field.
Collaborations
Susan has had the opportunity to collaborate with notable professionals such as Jinshan Michael Chen and Matthew Arnold Marx. These collaborations have enriched her research and development endeavors, fostering innovation and expanding the impact of her work in the pharmaceutical industry.
Conclusion
Susan LaGreca exemplifies the spirit of innovation and dedication that drives the field of pharmaceuticals forward. Her contributions through her patents reflect her commitment to advancing cancer treatment, and her collaborations highlight the significance of teamwork in achieving groundbreaking results. As she continues her work, Susan remains a key figure in the ongoing quest for effective medical solutions.